treating her2 mbc: immunotherapy and tkis
Published 4 years ago • 207 plays • Length 5:46Download video MP4
Download video MP3
Similar videos
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
2:43
sequencing treatment options in her2 positive breast cancer: 2023 best of breast conference
-
3:44
relapsed/refractory her2 mbc: future treatment landscape
-
0:50
dr. ellis on immunotherapy in her2 breast cancer
-
1:06
immunotherapy combination in her2-positive breast cancer
-
1:28
dr. tripathy on immunotherapy potential in her2-positive breast cancer
-
0:22
copy of dr. davis on immunotherapy in her2-positive gastric/gej cancer
-
1:33
dr. rimawi on the clinical need for immunotherapy in her2-positive breast cancer
-
4:05
sophia trial in r/r her2 mbc
-
0:57
dr. marks on the role of tkis in her2-positive breast cancer
-
53:19
her2 positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
1:24
nci minute: immunotherapy for metastatic breast cancer
-
6:08
first-line treatment of her2-positive metastatic breast cancer
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
0:45
dr. davis on immunotherapy in her2-positive gastric/gej cancer
-
1:54
dr. khong on endocrine combinations in er /her2- breast cancer